Roots Analysis

FEBRUARY 28, 2022

Considering patient’s health and safety, the drug products are expected to be free from microbial contamination and should be safe for use throughout the drug’s life cycle. One of the stages that require quality assurance is packaging of the drug product, as compromised packaging could have serious consequences.

Containment 52

Containment Packaging Packaging Contamination 52

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical companies hold permission to market their products directly to consumers. The direct-to-consumer marketing companies for pharmaceuticals are increasingly moving online as it supports the digitisation of information, enabling patients to take control of their health. No product is mentioned for help-seeking advertising.

Marketing 130

Marketing Compliance Doctors Doctor 130

Drug Patent Watch

JULY 11, 2021

Annual Drug Patent Expirations for BREVIBLOC+IN+PLASTIC+CONTAINER Brevibloc In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. The post New patent expiration for Baxter Hlthcare drug BREVIBLOC IN PLASTIC CONTAINER appeared first on DrugPatentWatch - Make Better Decisions.

Containment 52

Containment Drugs Marketing 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

Packaging plays a vital role in maintaining the quality, safety, user-friendliness and marketability of drugs and other pharmaceutical products. Finding the best commercial packaging suppliers in contract marketing. Pharmaceutical packaging formats and materials. Trends in pharmaceutical contract packaging.

Packaging 130

Packaging Packaging Marketing Containment 130

Pharmaceutical Technology

OCTOBER 31, 2022

GSK’s RSV older adult vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein antigen combined with proprietary AS01E adjuvant. If approved, GSK’s GSK-3844766A will be the first vaccine to reach the market for the prevention of RSV in older adults, gaining a significant first-mover advantage.

Vaccination 338

Vaccination Vaccine Marketing Trials 338

Pharma Mirror

NOVEMBER 4, 2022

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.

Marketing 130

Marketing Packaging Packaging Manufacturing 130

Drug Patent Watch

JULY 11, 2021

Annual Drug Patent Expirations for BREVIBLOC+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Brevibloc Double Strength In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from three….

Containment 52

Containment Drugs Marketing 52

Pharmaceutical Technology

JUNE 8, 2023

The European Commission (EC) has granted marketing authorisation for GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, for adults aged 60 years and above. Last month, Arexvy received approval from the US Food and Drug Administration (FDA ) for the same indication. overall efficacy against RSV-LRTD in adult patients.

Vaccination 147

Vaccination Vaccine Marketing Manufacturing 147

Pharmaceutical Technology

MAY 10, 2023

Gilead Sciences has emerged victorious in a legal battle with the US government over patents surrounding the HIV pre-exposure prophylaxis (PrEP) drugs Descovy and Truvada following a federal jury’s verdict on May 9. Gilead markets both Truvada and its successor Descovy.

FDA Approval 264

FDA Approval Drugs Containment Licensing 264

Drug Patent Watch

JANUARY 11, 2021

Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+IN+PLASTIC+CONTAINER Esmolol Hydrochloride In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available from one….

Containment 52

Containment Drugs Marketing 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

The increase in the production of biological drugs such as vaccines, gene and cell therapies, and monoclonal antibodies, is increasing the volume of injectable drug products in the global healthcare market. Discover the top commercial dose injectables companies in contract marketing.

Marketing 130

Marketing Containment Production Sales 130

Pharmaceutical Technology

SEPTEMBER 15, 2022

Various factors have contributed to the need and growth of API chemical suppliers such as rising healthcare expenditure, increasing disposable incomes, growing geriatric population, increasing incidence of chronic diseases, patent expiration of blockbuster drugs, increased consumption of generic drugs, and intervention of the new generation APIs.

Marketing 130

Marketing Manufacturing Generic Drugs Containment 130

Drug Patent Watch

SEPTEMBER 30, 2020

Annual Drug Patent Expirations for CARDENE+IN+4.8%25+DEXTROSE+IN+PLASTIC+CONTAINER 25+DEXTROSE+IN+PLASTIC+CONTAINER Cardene In 4.8% Dextrose In Plastic Container is a drug marketed by Chiesi and is included in one NDA. The post New patent for Chiesi drug CARDENE IN 4.8% It is available from two….

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

SEPTEMBER 30, 2020

Annual Drug Patent Expirations for CARDENE+IN+5.0%25+DEXTROSE+IN+PLASTIC+CONTAINER 25+DEXTROSE+IN+PLASTIC+CONTAINER Cardene In 5.0% Dextrose In Plastic Container is a drug marketed by Chiesi and is included in one NDA. The post New patent for Chiesi drug CARDENE IN 5.0% It is available from two….

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

JANUARY 11, 2021

Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Esmolol Hydrochloride Double Strength In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available….

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

SEPTEMBER 30, 2020

Annual Drug Patent Expirations for CARDENE+IN+0.83%25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER 25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER Cardene In 0.83% Sodium Chloride In Plastic Container is a drug marketed by Chiesi and is included in one NDA. It is available from….

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

SEPTEMBER 30, 2020

Annual Drug Patent Expirations for CARDENE+IN+0.86%25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER 25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER Cardene In 0.86% Sodium Chloride In Plastic Container is a drug marketed by Chiesi and is included in one NDA. It is available from….

Containment 52

Containment Drugs Marketing 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

Pharmaceutical drug research and development (R&D) activities are capital-intensive, which makes the outsourcing of clinical dose manufacturing and marketing popular. Find the leading clinical dose companies in contract marketing. Prospects of clinical dose companies in contract marketing.

Marketing 100

Marketing Contract Manufacturing Sales Clinical Trials 100

Pharmaceutical Technology

APRIL 24, 2023

However, the reality is that traditional medicine has been the source of lead identification in modern drug discovery. Ethnopharmacology has been an important basis for modern medicine The estimated percentage of pharmaceutical drugs available today that are sourced from natural products varies.

Medicine 262

Medicine Drugs Production Research 262

Pharmaceutical Technology

SEPTEMBER 8, 2022

Increasing drug failure rates and essential drug shortages have driven the growth of the compounding pharmacies market, which has a high growth potential, especially in emerging economies. Discover the top pharmaceutical compounding companies in contract marketing. Excipients. Active pharmaceutical ingredients (APIs).

Marketing 130

Marketing Pharmacy Containment Sales 130

BioTech 365

MARCH 9, 2021

Mydriasert: An Ophthalmic Insert Containing 0.28mg Tropicamide and 5.4mg Phenylephrine Hydrochloride – Global Drug Insight and Market Forecast to 2030 – ResearchAndMarkets.com Mydriasert: An Ophthalmic Insert Containing 0.28mg Tropicamide and 5.4mg Phenylephrine Hydrochloride – Global Drug Insight and Market Forecast … Continue (..)

Containment 40

Containment Marketing Drugs 40

Pharmaceutical Technology

SEPTEMBER 14, 2022

API peptides and proteins-based drugs have gained much attention in the past decade. More than 100 approved peptide-based therapeutics are currently available in the market. The increasing demand for API peptide products is in turn increasing the demand for peptide API manufacturers who also offer contract marketing services.

Protein 130

Protein Marketing Manufacturing Reagent 130

Pharmaceutical Technology

SEPTEMBER 20, 2022

Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. Identifying the top commercial dose (non-sterile) companies in contract marketing.

Marketing 130

Marketing Drug Delivery Systems Production Containment 130

The Pharma Data

SEPTEMBER 24, 2020

Some supplements billed as ‘smart drugs’ may contain unapproved drugs in potentially dangerous combinations and doses, according to a new study. The team looked through the National Institute of Health’s Dietary Supplement Label Database and the Natural Medicines Database for products containing unapproved drugs.

Containment 52

Containment Drugs Production Engineer 52

Pharma Mirror

FEBRUARY 18, 2022

By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The pharmaceutical industry works hard to create cutting-edge drugs to save lives and keep people healthy.

Packaging 130

Packaging Packaging Drugs Clinical Trials 130

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

Pharmaceutical Technology

SEPTEMBER 20, 2022

The increasing investment in pharmaceutical research and development, and the growing adoption of contract manufacturing and marketing practices are driving the demand for clinical trial contract packaging solutions. The post Leading clinical packaging companies in contract marketing appeared first on Pharmaceutical Technology.

Packaging 100

Packaging Packaging Marketing Clinical Trials 100

World of DTC Marketing

JUNE 6, 2021

SUMMARY: The media headlines promise weight loss for diabetes patients, but Norvo’s new drug is in the same class as other drugs and carries many warnings. Can diabetes patients really stay adherent to a drug for 63 weeks in which 85% of patients report GI side effects and will insurance cover the cost?

Drugs 318

Drugs Cosmetics Production FDA Approval 318

World of DTC Marketing

DECEMBER 2, 2020

Health spending for the calendar year may end up lower than it was in 2019 but spending on prescription drugs has not fallen which could be due to price increases. ” While the sample is too small to make any immediate judgments it should be worrying to DTC marketers. This is especially true for undiagnosed patients.

Marketing 155

Marketing Doctors Doctor Containment 155

XTalks

FEBRUARY 13, 2024

However, the line between enticing marketing and misleading information can sometimes blur, leading to controversies and legal actions. This dynamic has propelled misleading advertisement lawsuits into the spotlight, with several high-profile cases raising questions about the integrity of food marketing and its impact on consumer trust.

Marketing 59

Marketing Containment Production Packaging 59

Delveinsight

JANUARY 22, 2021

The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market.

Marketing 65

Marketing Drugs Antibody Compliance 65

FDA Law Blog

JANUARY 3, 2024

Palmer & Riëtte van Laack — Most of us love our furry friends, and with the boom in pet ownership during the pandemic, it is no surprise that the market for pet products has become enormous. CVM does not regulate the practice of veterinary medicine (that’s a state licensing board) or vaccines for animal diseases (that’s USDA).

Drugs 59

Drugs Licensing Licensing Production 59

Roots Analysis

DECEMBER 11, 2022

Antibody drug conjugates (ADCs) are an upcoming class of targeted therapeutic agents that have garnered the attention of pharmaceutical companies, and academic / research institutions across the world. Antibody drug conjugates market is presently an established therapeutic concept with 11 approved products.

Antibody 40

Antibody Marketing Contract Manufacturing Drugs 40

The Pharma Data

NOVEMBER 30, 2020

30, 2020 – Nearly 15% of talc-based cosmetic products analyzed in a recent study contained asbestos. She noted that EWG’s online database has identified more than 2,000 personal care products that contain talc, including more than 1,000 loose or pressed powders that could pose an inhalation risk. MONDAY, Nov. based institute.

Containment 52

Containment Production Cosmetics Contamination 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

Research by GlobalData (Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition) shows that containment facilities are in high demand as the use of cytotoxic drugs continues to grow. Adding to these factors is that oncology accounts for the majority of marketed, contained drugs.

Containment 130

Containment Manufacturing Production Contract Manufacturing 130

Roots Analysis

AUGUST 16, 2023

The success of COVID-19 vaccines paved the path for mRNA-based drug products. Market Landscape of mRNA Synthesis Kits Presently more than 95 mRNA synthesis kits, that contain reagents for the synthesis of research grade mRNAs with yield range up to 50,000 µg, are currently available in the market.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Marketing RNA 52

Pharma in Brief

AUGUST 5, 2020

DESCOVY contains a combination of tenofovir alafenamide ( TAF ) hemifumarate and emtricitabine. The Minister determined that TAF is a new chemical entity first approved in another Gilead drug product GENVOYA. Because DESCOVY contains TAF, it benefits from the same data protection term granted to GENVOYA. Background.

Containment 52

Containment Drugs Regulation Medicine 52